Effect of Cow's Milk Kefir on Short Chain Fatty Acid (SCFA), Haemoglobin, and Ferritin Levels of Anemic Adolescent Girls
Launched by LUSYANA GLORIA DOLOKSARIBU · May 2, 2025
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the effects of cow's milk kefir on young girls who have mild to moderate iron deficiency anemia. Anemia is a condition where you don't have enough healthy red blood cells, and it can lead to fatigue and weakness. The trial involves adolescent girls aged 15 to 18 who have been diagnosed with this condition. Participants will be randomly assigned to two groups: one group will drink cow's milk kefir daily along with a blood supplement, while the other group will drink regular cow's milk with the same supplement for two months.
Eligible participants are those who have a normal menstrual cycle and show signs of mild to moderate anemia. However, girls with certain blood disorders, those taking other supplements or antibiotics recently, or those who are lactose intolerant will not be included. Throughout the study, researchers will measure levels of important nutrients in the blood and the gut to see if cow's milk kefir can help improve the girls' health and reduce anemia. This study is a step towards finding better ways to manage anemia in young girls, especially in places where it's a common issue.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Adolescent girls aged 15-18 years
- • Have a mild and moderate degree of anemia (Hb 8-11.9 g/dl)
- • Have a normal menstrual cycle and duration
- Exclusion Criteria:
- • Suffering from thalassemia, hemosiderosis, blood cancer, and malaria, based on the doctor's diagnosis in the last 3 months
- • Taking supplements other than TTD
- • Taking antibiotics in the last 3 months
- • Suffering from lactose intolerance through interviews
About Lusyana Gloria Doloksaribu
Lusyana Gloria Doloksaribu is a dedicated clinical trial sponsor committed to advancing medical research and improving patient outcomes. With a focus on innovative therapeutic solutions, Lusyana leads a team of experienced professionals who design and manage clinical studies across various therapeutic areas. By fostering collaborations with healthcare providers and leveraging cutting-edge methodologies, Lusyana ensures the highest standards of safety and efficacy in clinical trials. Her commitment to ethical practices and regulatory compliance underscores her goal of delivering reliable and impactful medical advancements to the community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Yogyakarta, , Indonesia
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported